These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8125705)

  • 1. Terbinafine in onychomycosis--a mini study.
    Savin RC; Atton AV
    Int J Dermatol; 1993 Dec; 32(12):918-9. PubMed ID: 8125705
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
    Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
    J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group.
    Hofmann H; Bräutigam M; Weidinger G; Zaun H
    Arch Dermatol; 1995 Aug; 131(8):919-22. PubMed ID: 7632064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin.
    Hogan DJ
    J Am Acad Dermatol; 1995 Sep; 33(3):541-2. PubMed ID: 7657888
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group.
    Haneke E; Tausch I; Bräutigam M; Weidinger G; Welzel D
    J Am Acad Dermatol; 1995 Jan; 32(1):72-7. PubMed ID: 7822520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of the new antifungal drug therapies.
    Rand S
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):863. PubMed ID: 8632094
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Safer LF
    Acta Derm Venereol; 2000; 80(4):317-8. PubMed ID: 11028880
    [No Abstract]   [Full Text] [Related]  

  • 10. A questionnaire study on the management of onychomycosis: a Canadian perspective.
    Gupta AK; Shear NH
    Int J Dermatol; 1998 Jun; 37(6):457-60. PubMed ID: 9646138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis.
    Lebwohl MG; Daniel CR; Leyden J; Mormon M; Shavin JS; Tschen E; Weiss J; Zone J
    Int J Dermatol; 2001 May; 40(5):358-60. PubMed ID: 11555003
    [No Abstract]   [Full Text] [Related]  

  • 12. Terbinafine in onychomycosis of the toenail: a novel treatment protocol.
    Watson A; Marley J; Ellis D; Williams T
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):775-9. PubMed ID: 7593777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of toe-nail onychomycosis treated with terbinafine.
    Brandrup F; Larsen PO
    Acta Derm Venereol; 1997 May; 77(3):238. PubMed ID: 9188883
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
    Gupta AK; Lambert J
    Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
    [No Abstract]   [Full Text] [Related]  

  • 15. Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials.
    Haugh M; Helou S; Boissel JP; Cribier BJ
    Br J Dermatol; 2002 Jul; 147(1):118-21. PubMed ID: 12100193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for treatment of onychomycosis.
    Roberts DT; Taylor WD; Boyle J;
    Br J Dermatol; 2003 Mar; 148(3):402-10. PubMed ID: 12653730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine vs. placebo for onychomycosis in black patients.
    Billstein S; Kianifard F; Justice A
    Int J Dermatol; 1999 May; 38(5):377-9. PubMed ID: 10369551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.